Omico

Omico Facilitating, supporting, and promoting clinical trials in genomic cancer medicine.

At the release of Omico’s Impact Report, Chair Richard Vines captured Omico’s commitment clearly:“We hit every possible ...
13/01/2026

At the release of Omico’s Impact Report, Chair Richard Vines captured Omico’s commitment clearly:

“We hit every possible benchmark and we didn't waste a dollar… we will treasure every dollar like it's our last and make sure it always goes to the benefit of every patient. That's the promise of Omico.”

A reminder of the care, accountability and purpose behind this work.

Read more about our impact:
📘 Omico’s Impact Report – From Momentum to Mainstream: https://bit.ly/44JG6jY
📊 Omico’s Impact Scorecard: https://bit.ly/4rJKd9u

Australians can’t wait. It’s time to mainstream precision oncology for those who need it most.

Some stories are hard to tell — and even harder to relive.For International , we’re celebrating eight people living wit...
12/01/2026

Some stories are hard to tell — and even harder to relive.

For International , we’re celebrating eight people living with incurable cancer who joined with us, revisited deeply personal moments, and shared what molecular profiling and treatment matching meant for them. Real, lived experience.

❤️ Their courage helps others across Australia understand their options when cancer feels overwhelming.
🙏 To Emma, Matthew, Emily, Heidi, Beth, Caitlin, Marina and Jason—thank you for your candour, strength and generosity.

Link: https://www.omico.com.au/patients-and-families/

Matching

When Jason was first diagnosed with an incurable cancer, his oncologist referred him to Omico to have comprehensive geno...
09/01/2026

When Jason was first diagnosed with an incurable cancer, his oncologist referred him to Omico to have comprehensive genomic testing (CGP).

CGP provides extra information about a person’s cancer, including the specific features making it grow. This can help identify treatment options that precisely target these features. For Jason, that clearer picture mattered.

“CGP helps our understanding, and it helped me to treat Jason going forward.” – Dr Caroline Lum

Have you met the people that matched?
Watch the full episode here: https://vimeo.com/showcase/12028463

At the launch of Omico’s Impact Report, the Health Minister, Hon. Mark Butler MP, highlighted both the urgency and the o...
08/01/2026

At the launch of Omico’s Impact Report, the Health Minister, Hon. Mark Butler MP, highlighted both the urgency and the opportunity ahead:
💬“This is a really important piece of work…
It’s got so much potential — for the country, and for countless individual lives like Emily’s.”

His words reflect exactly why this work matters. The foundation for precision oncology is now in place and the opportunity to make it mainstream - accessible to Australians who need it - is right in front of us.

Read more about Australia’s progress:
📘 Omico’s Impact Report – From Momentum to Mainstream: https://bit.ly/44JG6jY
📊 Omico’s Impact Scorecard: https://bit.ly/4rJKd9u

Australians can’t wait. It’s time to mainstream precision oncology for those who need it most.

🎧 Two powerful podcasts. One shared message: knowledge brings hope.From Omico’s podcast to Podcast with Shelley Craf...
31/12/2025

🎧 Two powerful podcasts. One shared message: knowledge brings hope.

From Omico’s podcast to Podcast with Shelley Craft, the focus is clear — helping Australians better understand what’s possible in cancer care today.

Our 8 episode podcast series “Cancer Meets Its Match” is here to help you understand how comprehensive genomic profiling and precision oncology can be accessed and make a difference for Australians facing hard-to-treat cancers.

🎙 Hosted by Dr Ginni Mansberg you can find the full series here:

Our website: https://lnkd.in/g4b_4UBG
Apple Podcasts: https://lnkd.in/gSYAsaZV
Spotify: https://lnkd.in/gjyqEZwA
iHeart: https://lnkd.in/g8HpAHdg
Amazon: https://lnkd.in/gSVpcc4m

In her conversation with Professor David Thomas, Shelley Craft captures it perfectly: cancer carries fear, but science is delivering hope.

👉 Listen to the full episode now: https://lnkd.in/gKaeBjBf

Whether you’re living with cancer or supporting someone who is, these podcasts offer reassurance, understanding, and connection — helping listeners be informed, empowered, and not alone.

👉 Learn more about Omico: www.omico.com.au
📘 Download our Patient Information Booklet explaining precision oncology: https://bit.ly/3XHYdTk

Tag or share with someone who might find it helpful.

Professor David Thomas shared powerful evidence at the launch of Omico’s Impact Report.“Over almost a decade, more than ...
30/12/2025

Professor David Thomas shared powerful evidence at the launch of Omico’s Impact Report.
“Over almost a decade, more than two-thirds of the Australians we serve have had actionable biomarkers identified.”

The progress is clear:
60% in 2016 → 69% on average across the decade → 85% today.

As David said: “That’s 5 in 6 people who stand to benefit from molecular profiling today.”

This is why mainstreaming precision oncology matters.

Australians can’t wait.

📘 Omico’s Impact Report – From Momentum to Mainstream: https://bit.ly/44JG6jY
📊 Omico’s Impact Scorecard: https://bit.ly/4rJKd9u

28/12/2025

“Regardless of what cancer stage you are at, speak to your oncologist about comprehensive genomic testing.”

Comprehensive Genomic Profiling (CGP) gave Marina and her oncologist the crucial information needed to understand her challenging cancer and how to treat it.

It’s a conversation worth having early — particularly for people with advanced, incurable or poor-prognosis cancers. Your oncologist can help you understand how and when CGP might help guide your treatment options.

📽️Watch Marina’s story: https://vimeo.com/1130724354
📘Download our Patient Information Booklet and speak to your oncologist: https://qrco.de/bgARbU

At the launch of Omico’s Impact Report, Emily Lahey shared a message that resonated with everyone — including the Hon. M...
23/12/2025

At the launch of Omico’s Impact Report, Emily Lahey shared a message that resonated with everyone — including the Hon. Minister Mark Butler, MP.

💬“I stand here today because I had the opportunity to benefit from genomic testing and targeted therapy… My hope is that my story becomes the rule and not the exception.”

Emily’s story shows why mainstreaming precision oncology is so important.

Australians can’t wait.

📘 Omico’s Impact Report – From Momentum to Mainstream: https://bit.ly/44JG6jY
📊 Omico’s Impact Scorecard: https://bit.ly/4rJKd9u

As we head into the holiday season, we wish all our program participants, partners and stakeholders a peaceful and resto...
22/12/2025

As we head into the holiday season, we wish all our program participants, partners and stakeholders a peaceful and restorative break.

Our Cancer Screening Program (CaSP) team will continue to respond to enquiries during this period, with a reduced team operating from 23 December to 4 January.

📩Please contact us at casp@omico.org.au and we’ll respond as soon as we can.

At the launch of Omico’s Impact Report, our new Chair, Richard Vines, acknowledged what has been built:💬“About 10 years ...
22/12/2025

At the launch of Omico’s Impact Report, our new Chair, Richard Vines, acknowledged what has been built:
💬“About 10 years ago I was talking to David about his vision for Omico… I said to him that if you can do this, then what you would have created is a national treasure for this country. And he has.”

A powerful reminder of how far this vision has come to accelerate equitable access to precision oncology, and what’s now possible for Australians facing cancer.

Read more about this progress:
📘 Omico’s Impact Report – From Momentum to Mainstream: https://bit.ly/44JG6jY
📊 Omico’s Impact Scorecard: https://bit.ly/4rJKd9u

Australians can’t wait. It’s time to mainstream precision oncology for those who need it most.

After our Impact Report launch, Dr Mike Freelander MP gave a speech in Parliament recognising Omico’s work.He spoke warm...
18/12/2025

After our Impact Report launch, Dr Mike Freelander MP gave a speech in Parliament recognising Omico’s work.

He spoke warmly about our founder:
“Professor David Thomas is a rockstar in the medical world.”

He also underscored how precision oncology is already transforming care:
💬“Omico is really changing lives of many people.”
💬“We have cutting-edge genomic technologies that are turning into tangible therapeutic advancements for Australians with challenging cancers, improving outcomes across the board.”

We’re grateful to Dr Freelander for highlighting Omico’s impact — and the potential ahead.

🎥 Watch his speech: https://vimeo.com/1142726020

Read more about our impact:
📘 Omico’s Impact Report – From Momentum to Mainstream: https://bit.ly/44JG6jY
📊 Omico’s Impact Scorecard: https://bit.ly/4rJKd9u

Australians can’t wait. It’s time to mainstream precision oncology for those who need it most.

When Jason came to Caroline (his oncologist) and asked how they were going to fight his cancer, she didn't hesitate in r...
18/12/2025

When Jason came to Caroline (his oncologist) and asked how they were going to fight his cancer, she didn't hesitate in recommending comprehensive genomic profiling (CGP).

"We need to do CGP to understand your cancer...(and) what can we offer you that's matched to your type of cancer."

Current data from our Cancer Screening Program (CaSP), show that CGP identifies a biomarker with a matched therapy or clinical trial in around 85% of participants — opening the door to personalised options, as it did for Jason.

📽️Watch Jason’s full story: https://vimeo.com/1130722696
📘Download our Patient Information Booklet and speak to your oncologist: https://qrco.de/bgARbU

Address

370 Victoria St, Darlinghurst
Sydney, NSW
2010

Website

Alerts

Be the first to know and let us send you an email when Omico posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Omico:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category